Saturday - October 5, 2024
USM Maryland Momentum Fund and University of Maryland, Baltimore Invest in Irazu Oncology, Joining Wexford SciTech Fund, Abell Foundation, and Other Leading Investors
December 20, 2023
BALTIMORE, Maryland, Dec. 20 -- The University System of Maryland issued the following news release on Dec. 19, 2023:

Irazu Oncology, LLC ("Irazu"), a Baltimore-based therapeutics company, announced today that it closed a seed funding round to support development of the company's outer membrane vesicle (OMV) cancer vaccines platform. The round was led by the Wexford SciTech Venture Fund, with participation from the University System of Maryland (USM) Momentum Fund (Momentu . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products